** Macquarie downgrades Australia's Ansell ANN.AX to "Neutral" rating from "Outperform", trims price target to A$31.05 from A$40.30

** The new price target represents 5.6% premium to stock's close on Tuesday

** U.S. tariffs announced on April 4 present downside for ANN, despite the company expecting to fully offset tariff impacts through pricing - Macquarie

** ANN, known for its medical gloves and surgical gowns, has ~93% of its supply chain facing U.S. reciprocal tariffs greater than 10%, Macquarie says

** Two of 10 analysts rate the stock "buy" and eight "hold"; their median PT is A$38.10 – LSEG data

** Stock down 13.1% YTD

(Reporting by Sherin Sunny in Bengaluru)

((Sherin.Sunny@thomsonreuters.com;))